Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. - Wachtell,K.; Lehto,M.; Gerdts,E. (J Am Coll Cardiol, 2005)